CF PHARMTECH (02652) spent approximately 2.6372 million Hong Kong dollars on February 16 to repurchase 73,000 shares.
Chang Feng Pharmaceutical (02652) announced that on February 16, 2026, it spent approximately HK$2.6372 million to repurchase 73,000 shares.
CF PHARMTECH (02652) announced on February 16, 2026 a share buyback of approximately HKD 2.6372 million to repurchase 73,000 shares.
Related Articles
Tianli International Holdings Limited (01773) executive director Luo Shi increased his shareholding by 500,000 shares.
New Stock Preview | The fifth largest market share, Zero Intelligence: High customer concentration, with cash on hand of less than 0.4 billion yuan.
BUD APAC (01876) issued selected and restricted stock units.
Tianli International Holdings Limited (01773) executive director Luo Shi increased his shareholding by 500,000 shares.
New Stock Preview | The fifth largest market share, Zero Intelligence: High customer concentration, with cash on hand of less than 0.4 billion yuan.
BUD APAC (01876) issued selected and restricted stock units.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
